Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Redaporfin - Luzitin

Next Previous
Drug Profile

Redaporfin - Luzitin

Alternative Names: LUZ-11

Latest Information Update: 02 Apr 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bluepharma; Universidade de Coimbra
  • Developer Luzitin
  • Class Antineoplastics; Macrocyclic compounds; Porphyrins
  • Mechanism of Action Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase I/II Head and neck cancer

Most Recent Events

  • 02 Apr 2024 Phase I/II development is ongoing in Portugal (EudraCT2013-003133-14) (NCT02070432)
  • 28 Sep 2021 No development reported - Phase-II for Head and neck cancer (Late-stage disease) in Portugal (IV)
  • 02 Jun 2017 Adverse events, efficacy and pharmacokinetics data from a phase II trial in Head and neck cancer presented at the 53rd Annual Meeting of American Society of Clinical Oncology (ASCO-2017)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top